Price
Target price
€7.27
€7.27
3.580%
0.245
3.580%
€12.83
04.06.26 / Tradegate
WKN: A0LC2W / Symbol: EBS / Name: Emergent Bio / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Emergent Biosolutions Inc. Stock
A very strong showing by Emergent Biosolutions Inc. today, with an increase of €0.25 (3.580%) compared to yesterday's price.
Emergent Biosolutions Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 12 € there is a hugely positive potential of 65.18% for Emergent Biosolutions Inc. compared to the current price of 7.27 €.
Our community identified positive and negative aspects for Emergent Biosolutions Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Emergent Biosolutions Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc. | 3.580% | -7.921% | -0.548% | 32.187% | -30.077% | -5.342% | -86.282% |
| Ligand Pharmaceuticals | 2.970% | 0.990% | 4.082% | 126.667% | 22.892% | 193.525% | 120.112% |
| United Therapeutics | -0.820% | -2.300% | -5.168% | 66.056% | 10.367% | 132.544% | 225.241% |
| Ionis Pharmaceuticals Inc. | 0.880% | -2.531% | 0.248% | 110.475% | -4.797% | 65.897% | 127.977% |
Comments
Emergent Biosolutions (EBS) had its "buy" rating reaffirmed by Benchmark Co..
Show more
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (EBS) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (NYSE:EBS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
